Abstract Objective: Memory complaints increase as women transition from the premenopausal stage to the postmenopausal stage. We explored the extent to which subjective memory complaints were associated with objective cognitive test performance, affective symptoms, and menopausal symptoms in midlife women with moderate to severe vasomotor symptoms. We predicted that subjective memory complaints would be related to affective symptoms and lower performance on tests of memory and attention.
M emory complaints are a common symptom of the menopausal transition. Findings from the Study of Women's Health Across the Nation (SWAN) revealed a significant difference in the frequency of complaints of forgetfulness when comparing the premenopausal stage (31%) to the perimenopausal (41%) and postmenopausal (44%) stages. 1 Memory complaints were related to obtaining less than high school education, being older than 44 years, lacking fulltime employment, and having low levels of physical activity. 1 In the Seattle Midlife Women's Health Study, 62% of women noted an undesirable change in memory functioning, and they most often attributed the decline in memory to stress, health issues, and aging. 2 A follow-up study revealed that forgetfulness was related to hot flashes and difficulty concentrating. 3 Despite some differences, memory complaints among midlife women are high cross-culturally; in The Decisions at Menopause Study, more than 45% of women living in Massachusetts, Madrid, and Beirut complained of memory loss, compared with 34% of women living in Rabat, Morocco. 4 Three studies have investigated the relationship between subjective memory complaints and objective memory performance in women during the menopausal transition. In a study involving 120 premenopausal, perimenopausal, and postmenopausal women, lower verbal memory and attention performance, as well as mood symptoms, were associated with subjective complaints (ie, BDo you have problems with your memory?[). 5 However, stage of menopause did not influence this relationship. A second study of 24 perimenopausal women found a relationship between objective memory performance on the Rey Auditory Verbal Learning Test and subjective memory on the Memory Functioning Questionnaire (MFQ). 6 A larger follow-up study on 75 perimenopausal women found that depressive symptoms, somatic complaints, sleep, complex attention, and working memory performance were associated with subjective complaints on the MFQ. 7 Overall, across studies, subjective memory complaints were associated with mood symptoms and objective cognitive test performance; however, the cognitive domains associated with these complaints differed across studies (eg, attention, verbal memory, working memory).
In SWAN and other studies, self-reported hot flashes are unrelated to objective cognitive performance 8<10 ; however, in studies that do not include measures of objective cognitive performance, hot flashes have been shown to be a significant predictor of subjective forgetfulness. 11 Reports on the association between vasomotor symptoms and subjective memory complaints have been conflicting. In a study of women across the life span, vasomotor frequency was related to increased interference from memory problems during daily living and a higher likelihood of spontaneously reporting cognitive problems. 5 Furthermore, the intensity of hot flashes was positively associated with the duration of reported memory and attention problems. Conversely, there was no relationship between subjective memory complaints and self-reported vasomotor symptoms in two study populations of perimenopausal women. 6, 7 The aim of the present study was to extend studies of the relationship between objective and subjective memory complaints in midlife women to a sample of women with moderate to severe vasomotor symptoms. To this end, we measured subjective memory complaints and objective memory performance in a sample of 68 midlife women with at least 35 hot flashes per week. We included measures of menopausal symptoms (including vasomotor and sleep symptoms), measures of positive affect and negative affect, and a comprehensive neuropsychological test battery, including measures of episodic memory (ie, list learning, story recall), working memory, attention, and processing speed. Finally, as a primary outcome measure, we used a validated measure of subjective memory that had been previously used in a study of perimenopausal women. 5 We predicted that lower scores on objective cognitive tests and affective symptoms would predict increased subjective memory complaints. In addition, we predicted that higher vasomotor symptoms would be associated with more subjective memory complaints.
METHODS

Participants
Participants were recruited from a pool of women who were screened for entry into two related studies: (1) a randomized clinical trial comparing the effects of black cohosh, red clover, conjugated equine estrogens plus medroxyprogesterone acetate, and placebo on vasomotor symptoms 12 ; and (2) an ancillary study examining treatment-related effects on cognitive outcomes. 13 Women were recruited into the main clinical trial through Internet advertisements, bulletin board advertisements, and targeted mailings to women residing in the Chicago area. Inclusion criteria for the clinical trial included the following: (1) last menstrual period 6 months to 10 years before recruitment; (2) at least 35 hot flashes per week, as indicated by diaries completed for at least 2 weeks; and (3) intact uterus and ovaries. Exclusion criteria included the following: (1) use of hormone therapy, alternative botanical menopausal therapies, or oral contraceptives within 6 months of study entry; (2) smoking; (3) contraindications to hormone therapy (eg, vascular disease, hypertension, abnormal vaginal bleeding, history of blood clots, diabetes, abnormal mammogram); and (4) major systemic illness. Additional exclusion criteria for the ancillary cognitive study included the following: (5) diagnosis of an Axis I psychiatric disorder; (6) any medical condition that affects cognitive function (eg stroke, traumatic brain injury); (7) use of prescription or over-the-counter medications that affect cognitive function (eg, antidepressants, Gingko biloba); (8) first language other than English; and (9) participation in other clinical trials within 30 days. The data in this report were obtained before treatment initiation in women who volunteered to participate in an ancillary study that examined cognitive outcomes. 13 Seventy women were recruited; two women were excluded because English was not their first language, leaving 68 women in the final analyses. Table 1 presents the demographic characteristics of the 68 healthy midlife women who participated in the study. Participants ranged in age from 44 to 62 years (mean, 53.0 y). Before the initiation of treatment for the larger clinical trial, participants completed the entire cognitive battery in one visit, which lasted approximately 1.5 hours. The battery included the MFQ, menopausal symptom inventory, sleep inventory, and affective symptom scales. Demographic information was obtained at the beginning of the baseline visit. Each participant met oneon-one with a trained test administrator who was blinded to study treatment, menopausal stage, and the magnitude of subjective memory complaints when administering the battery. The cognitive test battery was modeled after the battery used in COGENT (COGnitive complaints in Early meNopause Trial), a study comparing the cognitive effects of combination hormone therapy and placebo on recently postmenopausal women with subjective cognitive complaints.
14 The test battery included the following measures.
Subjective menopausal symptom, mood, sleep, and memory outcomes
Greene Climacteric Scale
This questionnaire assessed bother of menopausal symptoms occurring Bat the moment.[ 15 The questionnaire contained 21 items that were scored on a 4-point Likert scale (0, not at all; 3, extremely). Four subcategories were measured: psychological symptoms, somatic symptoms, vasomotor symptoms, and sexual dysfunction.
Modified Pittsburgh Sleep Quality Index
This questionnaire was modified from the original Pittsburgh Sleep Quality Index 16 to measure latency to fall asleep, sleep duration, and sleep disturbances. Total sleep score was calculated using a previously published scoring scheme, with higher scores indicating greater sleep disturbance. 16 
Positive and Negative Affect Schedule
This 21-item self-report questionnaire measured positive and negative mood states. 17 
Memory Functioning Questionnaire
This questionnaire assessed subjective memory complaints. 18 Participants rated the frequency with which they experienced a series of memory lapses. Higher numbers indicated fewer subjective complaints. Each item was scored on a 7-point Likert scale (1, severe memory problems; 7, no problems). 14,20<23 The outcomes from the modified CVLT included total learning, short-delay free recall, and long-delay free recall. During learning, participants were read a list of 16 items from four semantic categories (eg, vegetables) three times; after each iteration, the participants were asked to recall as many of those items as possible. An interference list consisting of 16 words from four different semantic categories was read immediately after the end of the third learning trial. The participants were asked to recall as many words as possible from the interference list. After the interference recall, the short-delay recall trial was given, wherein the participants were prompted to recall as many words as possible from the original target list. Finally, after a 20-minute delay, the participants were again prompted to recall as many words from the original word list (long-delay free recall).
Logical memory subtest of the Wechsler Memory ScaleVRevised
Participants were read a brief story and informed that they would be asked to recall this story immediately and at a later time (30-min delay). 24 Outcome measures included standardized scores of story recall accuracy both immediately after presentation and after a 20-minute delay. Total scores ranged from 0 to 25.
Benton Visual Retention Test
This test assessed short-term figural memory. Participants viewed a line drawing for 10 seconds and were asked to immediately reproduce the drawing from memory on a blank piece of paper. 25 The complexity of the line drawing increased across each of 10 trials. The outcome was the total number of correctly reproduced drawings.
Modified card rotations test
This test measured visuospatial skills. 26 Participants were given 3 minutes to view a series of 20 line-drawing geometric figures, each accompanied by eight alternatives that were either a two-dimensional or a three-dimensional rotation of the target. The participants were instructed to mark targets that represented a two-dimensional rotation of the target as Bsame[ and to mark those that were three-dimensional rotations as Bdifferent.[ The outcome was the total number of correctly identified responses minus the number of incorrect responses, with a maximal score of 160.
Letter fluency
Participants were given 1 minute to generate as many words that begin with a particular letter as possible. 25 The outcome was the total number of words produced across three trials.
Digit Span Forward and Backward
This test assessed attention, short-term memory, and working memory. 24 For Digit Span Forward, the examiner read aloud a series of numbers and instructed the participant to repeat the series back to the examiner. For Digit Span Backward, the participant was again read a string of numbers and asked to repeat the string back in reverse order. The outcome measure was the number of correctly completed trials for each part.
Brief Test of AttentionVModified
This test measured auditory attention. 27, 28 During each of 20 trials, the examiner read aloud a list of numbers and letters, which increased in length and, therefore, difficulty. Participants were instructed to indicate the number of letters or numbers that were presented in each trial. The outcome was the total number of trials correctly completed.
Finding A's Test
This test assessed visuoperceptual speed and attention. 29 Participants were given sheets of paper each containing five columns of words, and each of these columns had five words containing the letter BA.[ The participants were given 2 minutes to cross out as many words containing the letter BA[ as possible. The outcome was the total number of correctly marked words.
Statistical analysis
We first checked the distribution of each variable for completeness, outliers, and distribution. Five individuals were missing items on the MFQ, and one individual was missing education; thus, missing data were recoded to the statistical mean of that variable. All variables were normally distributed, so analyses were conducted on raw scores. To avoid problems of multicollinearity, we created two composite z-scores: one for the CVLT and one for logical memory. The verbal memory composite score included the following CVLT measures: total words recalled across trials 1 to 3, short-delay free recall, and long-delay free recall. The logical memory composite measure included immediate recall and immediate delayed recall. For each of these, we first computed z-scores for individual tests and averaged these z-scores into composite z-scores. Next, we conducted a series of Pearson correlations between each of the MFQ outcomes and objective cognitive measures (CVLT composite, logical memory composite, all other individual cognitive measures), menopausal symptoms (vasomotor, sleep), positive affect and negative affect, and demographic characteristics (age, education). In subsequent multivariable linear regression analyses, we examined variables associated with the MFQ outcomes at P G 0.20. We only analyzed the individual measures comprising the composite scores when significant associations were found between the composite score and the MFQ outcomes (these models used the same covariates from the overall model). We performed manual forward and backward selection procedures to determine the best-fitting and most parsimonious models. We included in the final regression models those variables with trends toward significance (P e 0.10). All P values were two-sided, and the statistical significance level was set at P G 0.05. All analyses were performed using SAS version 9.2 (SAS Institute Inc., Cary, NC). Table 1 shows the demographic characteristics of the sample. Our sample ranged in age between 44 and 62 years. Women were primarily African American (54.4%), 3.6 years (on average) from their last menstrual period, and postmenopausal (79%). All participants had at least 12 years of education. As expected of women who report moderate to severe hot flashes, the burden of vasomotor symptoms was high when compared with other samples of midlife women. 14, 30 Positive affect and negative affect were similar to reported normative data in a large sample of adults (n = 1,003).
RESULTS
31 Table 2 presents the mean scores on neuropsychological tasks. Cognitive scores were all within reference limits and similar to scores in COGENT, which used a similar cognitive battery in younger postmenopausal women. Table 3 shows the variables that predicted Current Memory Rating and scores on the four MFQ subscales. Less negative affective symptoms and better objective memory performance on the CVLT composite predicted fewer complaints about Current Memory Functioning (Fig. 1) . Better objective memory performance on the long-delay trial of the CVLT significantly predicted fewer complaints about Current Memory Functioning (A = 0.24, P = 0.04), whereas trends were observed for total learning across trials 1 to 3 (A = 0.20, P = 0.09) and short-delay trial (A = 0.22, P = 0.055). Poorer performance on the Digit Span Forward and higher endorsement of negative affect significantly predicted more frequent forgetting on the Frequency of Forgetting scale, whereas a trend was observed for Digit Span Backward. Lower positive affect, more vasomotor symptoms, and increased age predicted worse Retrospective Functioning. Finally, older age predicted greater Use of Mnemonics. There were no significant predictors for the Seriousness of Forgetting subscale, and self-reported sleep quality did not relate to any subscale in the MFQ.
DISCUSSION
To our knowledge, the present study is the first to examine the relationship between subjective and objective memory complaints in a sample of women with moderate to severe hot flashes. Overall, the present study provides further validation that objective memory performance predicts the magnitude of subjective memory complaints in midlife women. Better subjective memory on a single item (BHow would you rate your memory in terms of the kinds of problems that you have?[) 19 related to better negative affect and better performance on an objective measure of delayed verbal memory. The other objective cognitive outcome that related to subjective memory was Digit Span Forward, which predicted Frequency of Forgetting. Affect was broadly predictive of subjective complaints. Hot flashes predicted worse scores on the Retrospective Memory Functioning subscale, which assessed the extent to which women felt that their memory had declined from an earlier point in life. Older chronological age predicted increased Use of Mnemonics. Cognitive test scores for this sample were within reference limits, so these relationships reflect detection of cognitive variations within the range of normal cognitive test performanceVnot the detection of any clinical significant impairment in performance.
Our general pattern of findings is quite similar to the findings of Weber et al, 7 who examined MFQ subscale scores in relation to similar predictor variables. Our sample included 68 midlife women (54% African American; mean age, 53 y; mean education, 15 y; 100% endorsing Q35 hot flashes per week), and the sample of Weber et al 7 was based on 75 perimenopausal women (91% white; mean age, 49 y; mean education, 16 y; 50% endorsing at least some hot flashes). Similar to the present study, Weber et al 7 found that more complaints of Frequency of Forgetting related to poorer attention and increased depressive symptoms, whereas more complaints of Seriousness of Forgetting related only to increased depressive symptoms. We found that global memory complaints related to both negative affect and objective cognitive performance, as measured on a delayed verbal memory test. Weber et al 7 used a summary variable computed across scales as an index of overall subjective memory. As in the present study, they found that overall subjective memory complaints related to both affect and objective cognitive performance, as measured by working memory. The consistency of findings from these two studies helps to validate women's subjective memory complaints during the menopausal transition.
Higher self-reported vasomotor symptoms were associated with more Retrospective Memory Functioning complaints, suggesting that women with more vasomotor symptoms experienced cognitive complaints longer than women with fewer vasomotor symptoms. These results parallel previous research showing that intensity of vasomotor symptoms was associated with a longer duration of memory and attention complaints. 5 On the other hand, two studies of perimenopausal women found no relationship between vasomotor symptoms and subjective memory complaints. 6, 7 A number of studies have examined the relationship between objective memory performance and hot flashes but found no association even in large samples of women studied in SWAN. 8<10,32 SWAN dichotomized self-reported hot flashes into symptomatic versus asymptomatic women. 32 Relationships between vasomotor symptoms and memory complaints may be most evident in highly symptomatic women and when vasomotor symptoms are examined as continuous variables.
Within the context of the broader cognitive literature, these results in midlife women are in agreement with some studies in older adults of both sexes, which find that MFQ scores relate to both depressive symptoms and objective cognitive performance, 19, 33, 34 but contrast with other studies. 35, 36 A review of studies comparing subjective and objective cognitive performance in adults of both sexes concluded that subjective memory complaints are not reliably related to cognitive impairment but are consistently related to depressive symptoms. 37 The review also concluded that current cognitive complaints were more strongly related to future cognitive impairment and dementia than to current cognitive impairment. 37 The clinical significance of memory complaints at midlife, particularly in women transitioning through menopause, has yet to be determined. Within this study population, objective cognitive performance was within expected ranges and did not suggest clinical impairment; however, recent neuroimaging studies in healthy middle-aged men and women have demonstrated that individuals with cognitive complaints show altered patterns of brain activation during the performance of cognitive tests of working memory when compared with those who have few complaints to no complaints. 38 This alteration in brain function was evident as reduced activation in the frontal cortex and was interpreted as indicative of brain vulnerability. A recent neuroimaging study showed that brain activation in the frontal cortex differed across premenopausal, perimenopausal, and postmenopausal groups of women who performed an in-scanner verbal encoding task, and these differences remained after controlling for age. 39 
CONCLUSIONS
We will gain better insights into the clinical significance of midlife memory complaints to later cognitive aging by conducting a continued longitudinal investigation of subjective and objective cognitive functions as women age reproductively and chronologically. The largest study of objective cognitive performance across the menopausal transition indicates that processing speed and memory decrease during perimenopause but return to expected levels during postmenopause. 32, 40 By contrast, subjective complaints increase with reproductive aging, with 40% to 65% of women endorsing some negative changes in their memory. 1, 2 It is known that depressive symptoms increase as women transition through menopause 41<44 ; notably, objective cognitive changes are maintained after accounting for depressive and anxiety symptoms. 32 Understanding the impact of perimenopausal depressive symptoms on the risk of cognitive dysfunction later in life is important because midlife depressive symptoms have been associated with the development of dementia later in life. 45, 46 The present study has several limitations. First, although the study provides new insights into memory in women with moderate to severe vasomotor symptoms, the generalizability of the findings may be limited because the sample is a convenience sample and is composed primarily of African-American women. Second, the study is cross-sectional and therefore does not address how the relationship between subjective and objective memory complaints might change with age or menopausal stage. Third, the study did not include a direct clinical measure of depressive symptoms. Fourth, sleep and vasomotor symptoms were measured by self-report rather than with objective measures.
The strengths of this study include the use of a comprehensive and well-validated measure of subjective memory function, the use of a comprehensive neuropsychological battery, and a new focus on women with moderate to severe vasomotor symptoms. Overall, this investigation strengthens the growing body of evidence indicating that women who have memory complaints across the menopausal transition accurately identify objective memory changes within the reference range of performance and that mood symptoms influence their judgment of the frequency and seriousness of those complaints.
